Health Systems — Exclusive Rights

OxyLuma^TM

Universal Ozone Engine &
Diagnostic Platform

Fighting Africa’s tropical diseases with rapid diagnostics and innovative therapies. One device. Multiple diseases. Real-time answers. Better outcomes.

REGA Global has secured exclusive rights to the OxyLuma platform — a transformative theranostic technology at the intersection of diagnostics, AI, and ozone-based therapy, strategically positioned in Ghana as the hub for Africa-wide impact.

<60

Minutes to Result

Diseases Detected

1B+

People at Risk

200K

Deaths/Day from Tropical Disease

$65B+

Annual Productivity Loss in Africa

The Platform

One Core Technology.
Limitless Applications.

The OxyLuma™ Universal Device is a fully integrated, portable diagnostic and therapeutic platform that brings laboratory-grade analysis to the point of care — in under 60 minutes, from sample to answer.

At its core, OxyLuma combines BDDE Ozone Technology with Multi-Spectral Imaging and AI-Powered Analysis to detect live pathogens across a wide spectrum of tropical diseases simultaneously. Unlike conventional diagnostics that identify dead biological markers, OxyLuma detects live, active pathogens — delivering clinically actionable data on infection load, drug resistance, treatment viability, and species identification in a single pass.

The platform processes blood, sputum, urine, stool, tissue aspirate, and CSF samples through a standardised four-step workflow: sample collection, fluidic processing, multi-spectral imaging and detection, and AI analysis with reporting. The result is a portable, robust, easy-to-use device that replaces an entire diagnostic laboratory.

BDDE Ozone Technology

A proprietary ozone generation and delivery system that enables both diagnostic enhancement and therapeutic ozone application within a single device architecture.

Multi-Spectral Imaging

Simultaneous imaging across multiple light spectra enables live pathogen visualisation, species differentiation, drug resistance identification, and viability scoring in a single imaging pass.

AI Analysis & Reporting

An embedded AI engine processes imaging data in real time, delivering quantified infection load, actionable treatment recommendations, and structured clinical reports — without laboratory infrastructure.

Platform Advantages

What Makes OxyLuma Different

🧬

Detects Live Pathogens

Not just dead biological markers. Live pathogen detection delivers clinically meaningful data on active infection.

📊

Quantifies Infection Load

Precise measurement of pathogen burden guides treatment intensity decisions and monitors therapeutic response over time.

🔬

Identifies Species & Strains

Species-level and strain-level identification enables targeted treatment selection and epidemiological tracking across populations.

💉

Detects Drug Resistance

Drug resistance markers identified at point of care, enabling immediate protocol adjustment and preventing treatment failure.

⚡

Results in <60 Minutes

From sample to actionable clinical answer in under 60 minutes — no laboratory, no specialist, no delay in treatment initiation.

📱

Portable & Field-Ready

Designed for deployment in remote clinics, field hospitals, border crossings, and community health centres with no laboratory infrastructure required.

Disease Coverage

Major Tropical Diseases OxyLuma Detects

Eight of Africa’s most devastating diseases — one device, one workflow, one result in under 60 minutes.

Tropical Disease

Malaria

Plasmodium spp.

Population at Risk

~236 Million

Detection Method

Giemsa Stain (Blood Smear)

Diagnostic Workflow

Blood sample → parasite enrichment → multi-spectral imaging → AI detection → drug resistance markers. Results <30 min.

Tropical Disease

Tuberculosis (TB)

Mycobacterium tuberculosis

Population at Risk

~110 Million

Detection Method

Acid-Fast Stain (AFB)

Diagnostic Workflow

Sputum sample → decontamination → concentration → multi-spectral imaging → viability detection → drug resistance. Results <60 min.

Tropical Disease

Leishmaniasis

Leishmania spp.

Population at Risk

~12 Million

Detection Method

Giemsa Stain (Amastigotes)

Diagnostic Workflow

Skin lesion/aspirate → parasite enrichment → multi-spectral imaging → species ID → treatment response. Results <45 min.

Tropical Disease

Schistosomiasis

Schistosoma spp.

Population at Risk

~251 Million

Detection Method

Microscopy (Eggs in Urine)

Diagnostic Workflow

Urine/stool → filtration → concentration → multi-spectral imaging → egg viability → infection scoring. Results <45 min.

Tropical Disease

Lymphatic Filariasis

Wuchereria bancrofti / Brugia spp.

Population at Risk

~51 Million

Detection Method

Microfilaria (Blood Smear)

Diagnostic Workflow

Blood (night) sample → concentration → multi-spectral imaging → species ID → treatment monitoring. Results <45 min.

Tropical Disease

African Trypanosomiasis

Trypanosoma brucei

Population at Risk

~70 Million

Detection Method

Blood Smear (Trypomastigotes)

Diagnostic Workflow

Blood/CSF → parasite enrichment → multi-spectral imaging → parasite viability → treatment monitoring. Results <60 min.

Tropical Disease

Soil-Transmitted Helminths

Ascaris, Hookworm, Trichuris spp.

Population at Risk

~1.5 Billion

Detection Method

Stool Microscopy (Eggs)

Diagnostic Workflow

Stool → concentration → multi-spectral imaging → egg/larvae ID → infection scoring. Results <45 min.

Tropical Disease

HIV

Human Immunodeficiency Virus

Population at Risk

~26 Million

Detection Method

Detection (p24 Antigen / Viral Particles)

Diagnostic Workflow

Blood → viral enrichment → multi-spectral imaging → antigen/RNA detection → viral load estimation. Results <45 min.

Strategic Deployment

Ghana — The Hub for
Africa-Wide Impact

Ghana has been selected as the strategic centre for the OxyLuma Africa-wide deployment. A stable democracy with strong healthcare infrastructure, Ghana sits at the centre of West Africa with direct access to the continent’s most disease-burdened populations, major regional trade corridors, and an established base of research universities and biotech talent.

The Africa Wide Diagnostic & Treatment Development Center will be established in Ghana as a hub for innovation, collaboration, and continental impact — combining research and innovation labs, clinical validation and trials capability, AI and data analytics, training and capacity building, manufacturing, and a pan-African distribution network.

→Stable democracy and supportive government environment

→Centre of West Africa — ideal connectivity for pan-African reach

→Access to top universities and research talent

→Gateway for pan-African partnerships and distribution

→Cost-effective operations and manufacturing base

Research & Innovation Labs

Dedicated facilities for ongoing platform development, new disease application research, and ozone therapy protocol design.

Clinical Validation & Trials

In-country clinical trial capability for WHO regulatory pathway, partnering with universities, governments, NGOs, and global health organisations.

Manufacturing & Pan-African Distribution

Local manufacturing for cost competitiveness and a distribution network reaching across the continent through established health system and NGO channels.

The Impact

Transforming Healthcare
for Millions

✅

Faster, Accurate Diagnosis

Real-time diagnosis at the point of care eliminates the delays that allow tropical diseases to progress to life-threatening severity.

⬇

Reduces Disease Burden

Earlier diagnosis and targeted treatment reduce mortality, lower transmission rates, and reduce the chronic disease burden on health systems.

💰

Lowers Healthcare Costs

Point-of-care diagnosis eliminates costly laboratory referral chains, reduces failed treatment costs from drug-resistant cases, and prevents hospitalisation.

🏗

Strengthens Health Systems

Distributed diagnostic capacity across Africa strengthens national health systems and builds lasting clinical and analytical infrastructure.

💼

Creates Jobs & Economic Growth

Manufacturing, distribution, clinical operations, and training create skilled employment and supply chain development across the continent.

🌍

Builds a Healthier Africa

A healthier workforce, reduced disease burden, and stronger health systems create the foundation for sustained economic productivity and development.

Flagship Deployment

Oxyluma Precision Health
Centre — Ghana

The Oxyluma Precision Health Centre is the flagship facility anchoring REGA’s Africa-wide deployment strategy — bringing point-of-care diagnostics, clinical validation, and community health services together under one roof in Ghana.

Platform Overview

Full Platform Schematic

A comprehensive overview of the OxyLuma™ platform, disease coverage, diagnostic workflows, and Africa-wide deployment strategy.

OxyLuma Universal Ozone Engine and Diagnostic Platform — full schematic

Partnerships

Academic Partners · Government Health Agencies · NGOs & Global Health Partners · Pharmaceutical & Biotech Partners · Funding & Investment Partners

Together, we can eliminate the burden of tropical diseases and transform healthcare for millions across Africa and beyond.

Explore Partnership Opportunities

OxyLumaTM

Universal Ozone Engine &Diagnostic Platform

One Core Technology.Limitless Applications.